LANDOS BIOPHARMA INC (LABP) Stock Earnings & Estimates
NASDAQ:LABP - US5150692011 - Common Stock
22.93 USD
+0.13 (+0.58%)
22.91 USD
-0.02 (-0.09%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18M | -100.00% | |||||||||||
| EBITDA YoY % growth | -13.19M -67.81% | -30.54M -131.54% | -38.62M -26.46% | -44.778M -2.74% | -22.746M 42.72% | -33.66M -48.11% | -45.084M -33.94% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.29M -67.38% | -30.68M -130.85% | -38.82M -26.53% | -43.478M -3.71% | -22.593M 43.55% | -28.203M -24.09% | -47.583M -68.72% | -90.168M -89.50% | -32.64M 63.80% | -32.64M | -32.64M | -32.64M | |
| Operating Margin | N/A | N/A | -215.67% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 57.35% | -10.33 -8.56% | -3.49 64.69% | -2.23 35.44% | -1.72 23.06% | -1.21 29.38% | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.89 -41.67% | -0.82 13.19% | -0.44 55.70% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.936M -56.22% | -7.191M -38.29% | -7.548M -14.19% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -1.43 -58.89% | -1.02 | -0.41 | -40.20% |
| Q4 2023 Q2Q % growth | -0.99 23.85% | -0.93 | -0.06 | -6.08% |
| Q3 2023 Q2Q % growth | -0.94 53.00% | -0.90 | -0.04 | -4.13% |
| Q2 2023 Q2Q % growth | -0.63 77.50% | -1.12 | 0.49 | 43.85% |
| Q1 2023 Q2Q % growth | -0.90 75.68% | -0.97 | 0.07 | 7.12% |
| Q4 2022 Q2Q % growth | -1.30 -282.36% | -1.94 | 0.64 | 32.92% |
| Q3 2022 Q2Q % growth | -2.00 -525.00% | -2.89 | 0.89 | 30.80% |
| Q2 2022 Q2Q % growth | -2.80 -2,433.33% | -3.72 | 0.92 | 24.79% |
| Q1 2022 Q2Q % growth | -3.70 -873.68% | -3.54 | -0.16 | -4.64% |
| Q4 2021 Q2Q % growth | 62.64% | -0.34 | % | |
| Q3 2021 Q2Q % growth | -0.32 | -0.45 | 0.13 | 28.47% |
| Q2 2021 Q2Q % growth | 0.12 | -0.14 | 0.26 | 184.03% |
| Q1 2021 Q2Q % growth | -0.38 | -0.38 | 0.00 | 0.65% |
| Q4 2020 Q2Q % growth | -0.91 | -0.70 | -0.21 | -29.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4.37% | 0% | 16.09% |
| Revenue | N/A | N/A | N/A | N/A |